Ani pharmaceuticals completes acquisition of novitium pharma, significantly enhancing r&d capabilities and scale of generics and cdmo businesses

Baudette, minn.--(business wire)--ani pharmaceuticals, inc. (nasdaq: anip) (ani or the company) today announced that it has completed the previously announced acquisition of novitium pharma, a privately held, new jersey-based pharmaceutical company with development, manufacturing, and commercialization capabilities. “today marks a major milestone for ani and the many patients who rely on our high-quality, cost-effective medications. with the completion of this acquisition, we bring on board a w
ANIP Ratings Summary
ANIP Quant Ranking